Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Shinichirou Iida"'
Publikováno v:
Clinical Case Reports, Vol 11, Iss 3, Pp n/a-n/a (2023)
Abstract Cardiac bradyarrhythmia and conduction disorder may be rare, but recurrent adverse events caused by bortezomib. Here we report a case with POEMS syndrome presenting severe heart block after bortezomib plus dexamethasone therapy. After perman
Externí odkaz:
https://doaj.org/article/dd3c0cc1bd304086ba1c7e2cdc9624ff
Publikováno v:
Clinical Case Reports. 11
Cardiac bradyarrhythmia and conduction disorder may be rare, but recurrent adverse events caused by bortezomib. Here we report a case with POEMS syndrome presenting severe heart block after bortezomib plus dexamethasone therapy. After permanent pacem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0488a60c01a5c117f818f990fd20225a
https://doi.org/10.22541/au.166852661.12069277/v1
https://doi.org/10.22541/au.166852661.12069277/v1
Publikováno v:
Haigan. 36:443-448
慢性腎不全維持透析中に肺小細胞癌を発症した61才女性にCarboplatin300mg/m2 (第1日), およびEtoposide50mg/m2 (第1, 3日) をともに1時間で点滴静注し, 点滴開始2時間後より, 4時間の透析を行うという
Publikováno v:
SEIBUTSU BUTSURI KAGAKU. 35:129-133
本研究では3'-Me-DAB誘発肝癌フェリチン(RHpF)の鉄取込みと ferroxidase 活性を測定し, 正常肝組織フェリチン (RLF) および心フェリチン (RHF) のそれと比較した. RHpFの等電点電気泳動は酸性にシ